muruganandan
southcott
bartlett
j
jayaram
l
rodrigu
hunt
j
bastiampillai
western
health
introduct
perform
bronchoscopi
commonli
use
investig
patient
possibl
pulmonari
tb
spontan
sputum
smear
neg
current
evid
bal
superior
bw
sputum
smear
neg
pulmonari
tb
gener
consensu
vari
clinician
aim
determin
perform
bal
yield
higher
diagnost
rate
compar
bw
alon
pulmonari
tb
method
prospect
studi
subject
n
possibl
activ
pulmonari
tuberculosi
diagnost
yield
bal
compar
bw
subject
either
produc
sputum
acid
fast
smear
neg
sputum
bal
bw
perform
patient
order
bal
bw
random
primari
outcom
percentag
cultur
posit
result
bw
bal
secondari
outcom
percentag
smear
posit
result
bw
bal
result
interim
analysi
data
n
demonstr
mean
sd
age
year
subject
mainli
vietnam
india
burma
five
subject
cultur
posit
result
bw
bal
one
subject
bw
cultur
neg
mycobacterium
tuberculosi
mtb
bal
cultur
posit
provid
addit
confirmatori
diagnosi
agreement
bw
bal
excel
cohen
kappa
yield
posit
smear
result
low
case
note
bw
bal
conclus
subject
either
expector
sputum
smear
neg
sputum
requir
bronchoscopi
ad
bal
standard
bw
mayb
clinic
indic
given
public
health
issu
import
make
firm
diagnosi
khandkar
c
harrington
z
dobler
c
depart
respiratori
medicin
liverpool
hospit
south
western
sydney
clinic
school
univers
new
south
wale
introduct
lymph
node
tuberculosi
lntb
common
form
tb
account
approxim
tb
case
australia
howev
data
lntb
spars
aim
describ
clinic
epidemiolog
characterist
peripher
lntb
comparison
pulmonari
tb
ptb
method
conduct
studi
compar
patient
peripher
lntb
randomli
select
patient
ptb
diagnos
sydney
tb
clinic
januari
decemb
epidemiolog
medic
data
extract
electron
hospit
databas
medic
record
data
examin
associ
lntb
age
sex
ethnic
bcg
vaccin
statu
comorbid
hiv
diabet
chronic
kidney
diseas
comparison
ptb
use
logist
regress
univari
multivari
analysi
result
case
lntb
randomli
select
control
ptb
among
patient
lntb
femal
mean
age
sd
year
among
patient
ptb
femal
mean
age
year
femal
year
old
southern
asian
increas
risk
lntb
odd
ratio
ci
ci
ci
respect
patient
diabet
higher
risk
ptb
ci
lntb
conclus
first
australian
studi
compar
epidemiolog
lntb
ptb
increas
risk
lntb
found
among
femal
peopl
age
year
peopl
born
southern
asia
increas
risk
ptb
found
among
patient
diabet
korver
batbayar
oyuntsetseg
tsolmon
solongo
wright
marai
dobler
mongolian
nation
tuberculosi
program
nation
centr
communic
diseas
ulaanbaatar
mongolia
univers
western
sydney
australia
mongolian
associ
mata
ulaanbaatar
mongolia
univers
sydney
australia
introduct
major
strength
mongolian
nation
tuberculosi
program
ntp
dedic
network
volunt
coordin
mongolian
associ
mata
provid
decentr
tuberculosi
tb
treatment
direct
supervis
aim
evalu
treatment
success
two
directli
observ
therapi
cdot
strategi
comparison
tradit
ulaanbaatar
mongolia
volunt
deliv
treatment
home
volunt
provid
treatment
patient
free
meal
cafe
contract
mata
method
analys
ntp
data
sputum
patient
commenc
tb
treatment
district
aimag
ulaanbaatar
assess
treatment
outcom
differ
dot
strategi
treatment
success
includ
cure
treatment
complet
base
definit
multivari
logist
regress
analysi
adjust
age
sex
occupationsocioeconom
statu
patient
categori
new
default
failur
relaps
transfer
result
sputum
tb
patient
receiv
patient
cdot
like
unemploy
patient
patient
unemploy
compar
median
age
interquartil
rang
iqr
year
patient
iqr
year
patient
iqr
patient
proport
male
among
respect
multivari
analysi
significantli
higher
treatment
success
ci
compar
conclus
higher
treatment
success
achiev
cdot
especi
tradit
detail
feasibl
analysi
seem
warrant
also
assess
valu
manag
brim
rosensteng
frank
yogendran
lee
read
hart
kay
water
lee
sir
chalr
gairdner
hospit
perth
wa
univers
western
australia
wa
pathwest
laboratori
medicin
royal
perth
hospit
wa
lung
institut
western
australia
introduct
frequent
mark
geograph
variat
bacteriolog
pleural
cultur
differ
nosocomi
commun
acquir
bacteriolog
undertook
analysi
pleural
fluid
cultur
public
hospit
perth
metro
area
western
australia
method
data
extract
pathwest
microbiolog
laboratori
databas
episod
code
posit
pleural
fluid
cultur
casenot
store
electron
health
record
data
review
demograph
length
stay
surviv
biochemistri
system
inflammatori
marker
result
case
posit
cultur
avail
analysi
median
age
year
male
right
side
differ
organ
isol
main
isol
summar
staphylococcu
aureu
streptococcu
viridan
aerob
mix
angiosu
group
rod
pseudomona
aeruginosa
e
coli
klebsiella
spp
mrsa
analysi
also
reveal
organ
never
report
associ
pleural
infect
eg
klebsiella
oxytoca
median
iqr
pleural
fluid
ph
glucos
mmoll
ldh
iul
white
cell
count
protein
mgl
median
surviv
follow
infect
day
case
infect
cai
infect
hai
compar
hai
cai
isol
angiosu
viridan
group
p
hai
mrsa
enterococci
klebsiella
spp
p
surviv
greater
cai
ci
p
conclus
elucid
local
bacteriolog
pleural
infect
may
reveal
uniqu
isol
pattern
popul
pleural
infect
associ
poor
prognosi
import
differ
exist
bacteriolog
outcom
commun
hospit
acquir
infect
viiret
birad
holm
kidd
depart
thorac
medicin
royal
adelaid
hospit
mycolog
unit
women
children
hospit
introduct
pulmonari
aspergillosi
signific
caus
morbid
mortal
immunocompromis
patient
accur
diagnosi
specif
treatment
improv
outcom
galactomannan
gm
major
constitu
aspergillu
cell
wall
releas
hyphal
growth
indic
activ
replic
bronchoalveolar
lavag
bal
gm
may
increas
diagnost
accuraci
optim
optic
densiti
od
determin
earlier
data
suggest
may
differ
immunocompromis
patient
aim
evalu
util
determin
optim
od
bal
gm
diagnosi
pulmonari
aspergillosi
immunocompromis
patient
method
immunocompromis
patient
requir
bronchoscopi
surveil
clinic
indic
three
year
period
patient
group
follow
categori
analysi
human
immunodefici
viru
infect
thorac
transplant
recipi
transplant
haematolog
malign
bone
marrow
transplant
recipi
etc
bal
specimen
analys
gm
use
immunosorb
assay
optim
od
calcul
use
receiv
oper
characterist
analysi
compar
current
gold
standard
direct
microscopi
fungal
cultur
result
bronchoscopi
perform
fungal
element
neg
patient
posit
fungal
cultur
posit
aspergillu
use
gold
standard
comparison
gm
overal
group
optim
od
subset
immunocompromis
patient
also
assess
thorac
transplant
recipi
group
allogen
bone
marrow
transplant
recipientsacut
leukaemia
group
optim
od
oncolog
malign
lymphoma
patient
higher
optim
od
conclus
bal
gm
increas
earli
detect
pulmonari
aspergillosi
immunocompromis
patient
optim
od
cut
differ
subgroup
reason
immunosuppress
consid
interpret
gm
result
annamalay
lanaspa
bizzintino
khoo
le
souef
bassat
school
paediatr
child
health
univers
western
australia
barcelona
centr
intern
health
research
hospit
universitat
de
barcelona
centro
de
de
aim
acut
lower
respiratori
infect
alri
lead
caus
childhood
mortal
worldwid
common
caus
viral
respiratori
infect
human
rhinoviru
hrv
despit
high
mortal
role
virus
childhood
alri
africa
poorli
understood
aim
describ
viral
aetiolog
alri
hospit
children
rural
mozambiqu
method
nasopharyng
aspir
collect
children
year
age
admit
district
hospit
fever
defin
clinic
pneumonia
part
studi
character
children
respiratori
distress
hiv
malaria
test
offer
patient
underw
chest
extens
clinic
laboratori
screen
respiratori
virus
adenoviru
respiratori
syncyti
viru
parainfluenza
viru
metapnuemoviru
bocaviru
enteroviru
influenza
coronaviru
identifi
use
two
independ
multiplex
assay
primer
specif
viru
viru
type
hrv
speci
genotyp
identifi
use
molecular
method
involv
rna
extract
pcr
amplif
sequenc
phylogenet
tree
analysi
result
total
children
male
mean
age
month
recruit
children
least
one
respiratori
viru
identifi
children
two
three
four
virus
identifi
children
respect
hrv
common
viru
identifi
follow
adenoviru
respiratori
syncyti
viru
parainfluenza
viru
metapnuemoviru
bocaviru
enteroviru
influenza
coronaviru
hrv
genotyp
specimen
hrv
associ
p
respiratori
symptom
includ
wheez
p
conclus
hrv
like
contribut
alri
hospit
children
mozambiqu
hiv
strong
impact
viral
infect
key
word
human
rhinoviru
acut
lower
respiratori
infect
perrin
jefferi
braithwait
walker
weatheral
jen
blackmor
beasley
univers
otago
medic
research
institut
new
zealand
canterburi
district
health
board
capit
coast
district
health
board
aim
influenza
respons
substanti
morbid
mortal
guidelin
suggest
antipyret
use
howev
fever
may
protect
effect
antipyret
increas
mortal
anim
influenza
model
investig
effect
paracetamol
viral
shed
clinic
symptom
adult
influenza
method
random
doubl
blind
trial
particip
ill
receiv
paracetamol
placebo
five
day
temperatur
record
five
day
symptom
score
record
day
pernas
swab
taken
quantit
viral
load
analysi
baselin
day
one
two
five
primari
outcom
variabl
area
curv
quantit
pcr
viral
load
day
zero
five
result
subject
enrol
none
lost
follow
twenti
two
particip
control
group
paracetamol
group
pcr
posit
influenza
signific
differ
group
primari
outcom
measur
auc
quantit
pcr
log
viral
load
day
control
group
minu
paracetamol
group
ci
p
signific
differ
group
secondari
virolog
clinic
outcom
regular
paracetamol
signific
effect
temperatur
symptom
compar
placebo
group
conclus
regular
paracetamol
signific
effect
temperatur
symptom
viral
shed
patient
influenza
lower
expect
posit
pcr
rate
henc
studi
may
underpow
detect
differ
lack
efficaci
paracetamol
antipyret
meant
abl
suffici
suppress
fever
work
requir
order
defin
role
fever
influenza
infect
regular
administr
paracetamol
antipyret
influenza
recommend
aiyappan
mangira
lenghau
morton
flinder
medic
centr
flinder
univers
repatri
gener
hospit
flinder
medic
centr
introduct
antibiot
restrict
polici
place
larg
number
hospit
decreas
emerg
organ
prevent
howev
need
effect
restrict
special
unit
assess
previous
aim
compar
antibiot
prescrib
patient
admit
commun
acquir
pneumonia
cap
respiratori
unit
two
teach
campus
within
region
adelaid
flinder
medic
centr
fmc
administr
control
antibiot
prescrib
repatri
gener
hospit
rgh
administr
control
antibiot
prescrib
method
multicentr
retrospect
observ
studi
result
total
patient
admit
diagnosi
cap
fmc
rgh
fmc
femal
rgh
femal
major
patient
rgh
pneumonia
sever
index
psi
score
iv
v
fmc
patient
psi
iii
psi
iv
psi
v
cap
guidelin
follow
patient
fmc
compar
rgh
fisher
test
p
one
patient
antibiot
associ
advers
event
fmc
compar
none
rgh
one
death
hospit
averag
length
stay
significantli
differ
day
fmc
day
rgh
conclus
adher
respiratori
unit
cap
guidelin
studi
high
irrespect
administr
antibiot
restrict
presenc
restrict
increas
adher
guidelin
suggest
well
produc
guidelin
adequ
educ
staff
may
make
prescrib
limit
unnecessari
especi
special
unit
deal
infect
involv
area
expertis
burr
roger
chen
serisi
mater
research
mater
health
servic
brisban
qld
background
aim
aim
experi
assess
level
express
fibrosi
bronchiectasi
subject
compar
healthi
control
nuclear
receptor
gene
express
wide
lung
low
level
airway
associ
increas
likelihood
p
aeruginosa
posit
cystic
fibrosi
lung
postul
p
aeruginosa
quorum
sens
molecul
lacton
antagon
inhibit
transcript
method
forti
one
bronchiectasi
subject
healthi
control
underw
fibreopt
bronchoscopi
sampl
collect
lavag
fluid
messeng
rna
extract
sampl
revers
transcrib
total
cdna
use
random
hexam
primer
express
gene
encod
measur
use
real
time
pcr
level
normal
beta
actin
gene
express
result
express
lower
bronchiectasi
subject
compar
control
p
lower
patient
pcr
posit
p
aeruginosa
p
invers
correl
p
aeruginosa
load
rs
p
seen
either
total
bacteri
load
rs
p
haemophilu
influenza
load
rs
p
express
posit
correl
absolut
macrophag
count
rs
p
consist
invers
correl
p
aeruginosa
total
macrophag
level
rs
p
conclus
express
airway
bronchiectasi
subject
significantli
reduc
compar
healthi
individu
reduct
correl
lower
level
macrophag
cell
type
gene
highli
express
increas
level
p
aeruginosa
whether
reduct
pure
reflect
low
macrophag
level
due
interact
p
aeruginosa
warrant
studi
tang
van
ly
read
bain
spann
burgess
black
hartl
oliv
woolcock
institut
medic
research
depart
microbiolog
immunolog
univers
melbourn
centr
asthma
respiratori
diseas
hunter
medic
research
institut
respiratori
viru
research
unit
clinic
medic
virolog
centr
sir
albert
sakzewski
viru
research
centr
depart
pediatr
univers
introduct
neutrophil
import
control
infect
particular
respiratori
viru
infect
time
increas
neutrophil
number
product
neutrophil
inflamm
associ
sever
asthma
symptom
corticosteroid
insensit
role
asthma
exacerb
neutrophil
directli
respond
respiratori
virus
fulli
understood
aim
investig
neutrophil
activ
viral
surrog
tlr
agonist
differ
infecti
respiratori
virus
identifi
whether
asthmat
neutrophil
respond
differ
viral
surrog
method
peripher
blood
sampl
collect
mild
asthmat
n
individu
n
neutrophil
stimul
lp
fmlp
nm
imiquimod
poli
c
rhinoviru
rv
moi
respiratori
syncyti
viru
rsv
moi
influenza
viru
moi
cell
free
supernat
collect
h
measur
neutrophil
elastas
ne
matrix
metalloproteinas
mmp
releas
h
interleukin
il
releas
result
lp
fmlp
imiquimod
stimul
releas
ne
howev
poli
c
induc
releas
differ
asthmat
neutrophil
respons
except
neutrophil
asthmat
patient
releas
significantli
control
patient
p
rsv
caus
releas
ne
neutrophil
howev
influenza
viru
caus
releas
three
mediat
measur
conclus
neutrophil
detect
respond
viral
surrog
releas
ne
howev
neutrophil
mount
respons
influenza
viru
detect
respond
rsv
respiratori
virus
may
induc
neutrophil
inflamm
directli
form
inflamm
may
result
neutrophil
interact
adjac
infect
cell
lee
varnao
rashwan
water
townsend
kay
respiratori
depart
sir
charl
gairdner
hospit
centr
asthma
allergi
respiratori
research
school
medicin
pharmacolog
lung
institut
western
australia
depart
microbiolog
infecti
diseas
royal
perth
hospit
aim
evalu
character
vitro
cytokin
effect
bacteri
pleural
pathogen
mesotheli
cell
method
benign
pleural
mesotheli
cell
line
treat
live
staphylococcu
aureu
refer
strain
clinic
isol
streptococc
speci
hr
interleukin
il
vascular
endotheli
growth
factor
vegf
releas
determin
immunosorb
assay
media
subject
protein
fraction
base
molecular
weight
use
centrifug
filter
unit
millipor
result
live
aureu
refer
strain
induc
vegf
releas
cell
manner
result
verifi
use
aureu
clinic
isol
obtain
blood
cultur
convers
streptococcu
pneumonia
milleri
group
bacteria
induc
cytokin
releas
cell
vegf
releas
mediat
via
bacteri
exoproduct
resist
heat
deoxyribonucleas
ribonucleas
treatment
select
aureu
condit
media
reveal
activ
retain
concentr
contain
exoproduct
kda
size
conclus
common
bacteri
empyema
pathogen
aureu
induc
releas
cytokin
test
pleural
mesotheli
cell
vitro
result
use
bacteria
condit
media
indic
caus
factor
activ
secret
product
aureu
